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Abstract
Background: A decrease in blood lactate levels (Lac) >10% during the first hours of resuscitation in sepsis is
associated with better outcomes, but the mechanisms are unclear. Our objective was to investigate the relationship
between the time course of Lac, inflammatory response, and mitochondrial respiration during experimental sepsis.
Methods: Original data from two previously published studies were reanalyzed. In cohort 1, pigs were randomized
to be resuscitated for 48 h starting at 6, 12, and 24 h, respectively, after fecal peritonitis induction (n = 8 each). Animals
were categorized according to the decrease in Lac during the first 6 h of resuscitation (early if ≥10% [Lac ≥10%] or late
if <10% or increased [Lac <10%]), and systemic hemodynamics, inflammatory parameters, and mitochondrial function
were compared between groups. In a second group of animals with fecal peritonitis and 24 h of resuscitation
(n = 16, cohort 2), abdominal regional Lac exchange was measured, and animals were categorized according to
the decrease in Lac as in cohort 1.
Results: Overall mortality was 20% (4 of 20) in the Lac ≥10% group and 60% (12 of 20) in the Lac <10% group
(p = 0.022). In cohort 1, systemic hemodynamics were similar in the Lac ≥10% (n = 13) and Lac <10% (n = 11)
groups. Plasma interleukin-6 levels increased during unresuscitated sepsis and decreased during resusciation in
both groups, but they were lower at study end in the Lac ≥10% group (p = 0.047). Complexes I and II maximal
(state 3) and resting (state 4) isolated brain mitochondrial respiration at study end was higher in the Lac ≥10%
group than in the Lac <10% group, whereas hepatic, myocardial, and skeletal muscle mitochondrial respiration
was similar in both groups. In cohort 2, mesenteric, total hepatic, and renal blood flow at study end was higher
in the Lac ≥10% group (n = 7) than in the Lac <10% group (n = 9), despite similar cardiac output. Hepatic lactate
influx and uptake in the Lac ≥10% group were approximately 1.5 and 3 times higher, respectively, than in the
Lac <10% group (p = 0.066 for both).
Conclusions: A decrease in Lac >10% during early resuscitation (6 h) after abdominal sepsis is associated with
lower levels of plasma interleukin-6 and improved brain but not hepatic or muscle mitochondrial respiration.
Blood flow redistribution to abdominal organs in animals with early decrease in Lac concentrations increases the
potential to both deliver and extract Lac.
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Background
Hyperlactatemia and lactic acidosis are widely accepted
as strong predictors of multiple-organ dysfunction and
death in different populations of critically ill patients [1–5].
Measurement of blood lactate (Lac) for the management
of severe sepsis and septic shock has been strongly recom-
mended since the first publication of the international
sepsis guidelines [6, 7].
Although there are no single or direct interventions
available to reverse hyperlactatemia, it has been
proposed that Lac could be used as a guide during early
resuscitation of patients with sepsis [8, 9]. It has been
shown that a decrease in blood Lac levels >10% during
the first 6 h of resuscitation is associated with reduced
in-hospital mortality [10]. Interestingly, in another study,
mortality was improved in the group with the goal of
early Lac decrease despite the fact that achieved Lac
values did not differ between the intervention and
control groups [8].
In the last 2 decades, the assumption that high Lac
levels represent a consequence of anaerobic metabolism
has been challenged [11]. Other factors not related to
insufficient tissue oxygen delivery may contribute to
hyperlactatemia, such as impaired aerobic respiration,
accelerated aerobic glycolysis, and reduced Lac uptake
by the liver [12].
We recently demonstrated that treatment delay in
fecal peritonitis increased inflammatory markers and Lac
concentrations and was associated with impaired cere-
bral mitochondrial respiration at the end of the resusci-
tation period [13]. However, all these variables varied
widely in individual animals [13]. In the present investi-
gation, we hypothesized that animals with a greater de-
crease in blood Lac levels during the early resuscitation
period would exhibit a less intense inflammatory re-
sponse and preserve better mitochondrial respiration.
To evaluate a possible contribution of gut and hepatic
Lac handling to time course of blood Lac levels, we rea-
nalyzed a second group of animals with fecal peritonitis
where these measurements were available [14].
Methods
We used original data from two previously published
studies [13, 14]. The studies were performed in accord-
ance with the National Institutes of Health Guide for the
Care and Use of Experimental Animals and with the ap-
proval of the Animal Care Committee of the Canton of
Bern, Switzerland.
The first study (cohort 1) was designed to address the
impact of three different treatment delays (i.e., resuscitation
initiated 6, 12, or 24 h after induction of fecal peritonitis)
on disease severity, development of sepsis-associated organ
dysfunction, and mitochondrial function [13]. In the second
study (cohort 2), the impact of two different fluid
resuscitation strategies (moderate-volume and high-volume
expansion) on mortality, sepsis-associated organ dysfunc-
tion, and mitochondrial function in animals subjected to
either fecal peritonitis or endotoxin infusion were evaluated
[14]. For cohort 2, only data from animals challenged with
fecal peritonitis were included. The full study protocols of
the original studies can be found elsewhere [13, 14].
Cohort 1
Experimental protocol
Fecal peritonitis was induced by peritoneal instillation of
2 g/kg body weight of autologous feces dissolved in
200 ml of 5% glucose solution. Thirty minutes after
surgery, baseline (BL) measurements were taken. Then
animals (n = 8 per group) were randomized to a sham
control group or one of three groups in which resuscita-
tion was started 6, 12, or 24 h after peritonitis induction.
The 48-h resuscitation period consisted of broad-
spectrum antibiotics (piperacillin/tazobactam [Tazobac®;
Savoy, Manimajra, India] 2.25 g intravenously) adminis-
tered every 8 h, volume expansion (alternating bolus of
150 ml of Ringer’s lactate and 6% hydroxyethyl starch
130/0.4 [HES]), vasopressors, and inotropes wherever
necessary to reach predefined hemodynamic goals [13].
Blood gas analyses
Blood samples were drawn from an indwelling carotid
artery catheter for Lac measurement (in millimoles per
liter) (GEM Premier 3000 analyzer; Instrumentation
Laboratory, Bedford, MA, USA) at BL and every 6 h
during the resuscitation period. Inflammatory markers
(plasma interleukin-6 [IL-6], tumor necrosis factor-α
[TNF-α], and C-reactive protein [CRP]) were measured
in blood samples drawn from the carotid artery at BL,
immediately before starting resuscitation maneuvers
(BR), and at the end of the experiment as previously
described [13].
Mitochondrial function and skeletal muscle adenosine
triphosphate content
At BL, BR, and the end of the experiment, tissue samples
were taken from the right quadriceps muscle to assess
mitochondrial function and skeletal muscle adenosine tri-
phosphate (ATP) content as previously reported [13].
Additional tissue samples were taken from the brain, liver
(left lobe), and heart (left ventricle) at the end of the ex-
periment [13]. In animals that died earlier, the final tissue
samples were taken when the animals were still alive,
were receiving the maximal norepinephrine dose
(1000 μg/h), and when mean arterial blood pressure
approached 30 mmHg [13].
Oxygen consumption by complexes I, II, and IV was
measured using high-resolution respirometry (Oxygraph-
2 k; Oroboros Instruments, Innsbruck, Austria) and was
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expressed as picomoles per second per milligram of
mitochondrial protein. State 3 represents active respir-
ation after addition of adenosine diphosphate (ADP),
whereas state 4 represents respiration after depletion of
ADP. The respiratory control ratio, an indicator of
coupling between respiration and ATP phosphorylation,
was calculated by dividing state 3 by state 4 respiration
rates [13]. The time course of blood Lac levels was de-
fined as change in blood Lac levels in percent during
6 h of resuscitation [15].
Cohort 2
Surgical preparation
With animals in supine position, a midline laparotomy
was performed, and the abdominal cavity was exposed
[14]. Catheters for pressure monitoring and blood
sampling were inserted into the carotid, hepatic, and
pulmonary arteries and into the jugular, hepatic, portal,
mesenteric, splenic, and renal veins [14]. A large-bore
catheter for fluid administration was inserted into the
femoral vein. Ultrasound Doppler flow probes (Transonic®
Systems Inc., Ithaca, NY, USA) were placed around the ca-
rotid, superior mesenteric, splenic, hepatic, celiac trunk,
and renal arteries and around the portal vein. A
drainage catheter was inserted into the urinary blad-
der. Finally, two large-bore drains were inserted into
both flanks of the animals [14]. The surgical proced-
ure was followed by a 12-h period of hemodynamic
stabilization.
Experimental protocol
Fecal peritonitis was induced by peritoneal instillation
through a peritoneal drainage tube of 1 g/kg body
weight of autologous feces dissolved in 200 ml of 5%
glucose solution [14]. The intraperitoneal drains were
maintained clamped during the following 6 h. Before
fecal peritonitis induction, animals were randomized to
either moderate-volume (10 ml/kg/h Ringer’s lactate) or
high-volume (15 ml/kg/h Ringer’s lactate + 5 ml/kg/h
HES) (n = 8 each) fluid resuscitation for 24 h or until
death, if earlier. Resuscitation started immediately after
fecal peritonitis induction. Wherever necessary to reach a
pulmonary arterial occlusion pressure >5 mmHg or urin-
ary output >0.5 ml/kg/h, an additional fluid bolus (50 ml
of HES) was given as long as stroke volume increased
≥10%. Vasopressors and inotropes were not used [14].
Blood measurements
Hemoglobin and oxygen saturation were analyzed at BL
(before fecal peritonitis induction) and every 6 h thereafter
(OSM3; Radiometer, Copenhagen, Denmark). At the same
time, blood gases were measured and values corrected for
temperature using a blood gas analyzer (ABL520; Radiom-
eter), and arterial and venous blood Lac levels were mea-
sured with a Lac analyzer (YSI 2300 STAT PLUS; YSI Life
Sciences, Yellow Springs, OH, USA) [14].
Calculations
In contrast to cohort 1, where resuscitation was delayed
for 6–24 h, resuscitation in cohort 2 started immediately
Fig. 1 Time course of blood lactate (Lac) levels in cohort 1 animals. a Changes in blood Lac levels during the first 6 h of resuscitation accordingly
to study group. b and c Individual arterial Lac levels before starting resuscitation maneuvers (BR) and after the first 6-h resuscitation period (RP 6 h) in
the Lac ≥10% and Lac <10% groups. Filled circles in (a) represent animals that died during the 48-h resuscitation period. Red horizontal bars represent
median values
Corrêa et al. Critical Care  (2017) 21:105 Page 3 of 12
after fecal peritonitis was induced. Therefore, BL for Lac
time-course analysis in cohort 2 was considered after
6 h of resuscitation, corresponding to the shortest resus-
citation delay in cohort 1 and the time point of
maximum Lac levels.
Systemic oxygen delivery and consumption were cal-
culated according to standard formulas [16, 17]. Hepatic
Lac influx (in micromoles per kilogram per minute) was
calculated as follows: (portal venous Lac × portal vein
blood flow) + (arterial Lac × hepatic arterial blood flow).
Hepatic Lac efflux (in micromoles per kilogram per
minute) was calculated as follows: hepatic venous
Lac × (portal venous + hepatic arterial blood flow). Hepatic
Lac uptake (in micromoles per kilogram per minute) was
calculated as follows: hepatic Lac influx − hepatic Lac ef-
flux. Other regional Lac exchanges (spleen, gut, kidney,
and lung) were calculated as follows: regional Lac influx −
regional Lac efflux. Whole-body venous efflux (in micro-
moles per kilogram per minute) was calculated as follows:
cardiac output ×mixed venous Lac concentration. Extra-
hepatic organ Lac efflux was calculated as follows: (cardiac
output ×mixed venous Lac concentration) − hepatic Lac
efflux [17].
Statistical analysis
In each cohort, animals were classified according to their
time course of blood Lac levels: early (≥10% Lac de-
crease, Lac ≥10%) vs. late (<10% Lac decrease or in-
crease, Lac <10%). All data are presented as mean ± SD,
or as median with IQR in cases of non-normal distribu-
tion (tested by the Kolmogorov-Smirnov test).
Proportions between groups were compared with
Fisher’s exact test. Survival analysis was performed using
the Kaplan-Meier method, and the log-rank test was
Fig. 2 Kaplan-Meier curves for 48-h survival after the beginning of
resuscitation in cohort 1
Table 1 Administered treatment, fluid output, and balance in cohort 1 study
Parameters Lac ≥10% Lac <10% p value
Propofol, mg/kg/h 5.7 (5.1–6.2) 5.5 (4.9–5.9) 0.459a
Fentanylb, μg/kg/h 4.9 (4.5–5.7) 5.2 (5.0–8.1) 0.072a
Midazolam, mg/kg/h 0.05 (0.04–0.06) 0.06 (0.05–00.7) 0.331a
Fluid bolusc,d, ml/kg/h 0.80 (0.53–1.24) 1.68 (0.50–2.82) 0.186a
Ringer’s lactate 0.45 (0.30–0.65) 0.84 (0.28–1.75) 0.186a
HES 0.39 (0.23–0.58 0.84 (0.21–1.07) 0.150a
Norepinephrine
n/Total n, % 7/13 (53.8) 8/11 (72.7) 0.423e
Dose, μg/kg/minute 0.02 (0.01–0.07) 0.10 (0.06–0.22) 0.054a
Dobutamine
n/Total n, % 2/13 (15.4) 5/11 (45.5) 0.182e
Dose, μg/kg/minute 1.89 (0.65–3.13) 0.44 (0.33–0.58) 0.190a
Total volume receivedf, ml/kg/h 3.61 (3.49–4.11) 4.12 (3.43–5.39) 0.303a
Urine output, ml/kg/h 1.00 (0.96–1.15) 1.21 (0.99–1.36) 0.134a
Gastric tube output, ml/kg/h 0.22 (0.05–0.30) 0.42 (0.22–0.71) 0.036a
Final balanceg, ml/kg/h 2.48 (2.15–2.75) 2.45 (1.93–4.13) 1.000a
HES 6% Hydroxyethyl starch 130/0.4, Lac Lactate
Values are median (IQR) or n/total n (%) when indicated
aMann-Whitney U test
bSum of basic fentanyl infusion with additional bolus
cSum of Ringer’s lactate and HES
dAdministered during resuscitation period
eFisher’s exact test
fSum of Ringer’s lactate basal infusion + 50% glucose basal infusion + Ringer’s lactate bolus + HES
gFinal balance = total volume received − (urine output + gastric tube output)
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used for between-group comparisons. Continuous vari-
ables (administered treatments; fluid output and balance;
brain, liver, and heart mitochondrial respiration) were
compared between groups with an independent-samples
t test or with the Mann-Whitney U test in cases of non-
normal distribution.
Repeated measurements were assessed by analysis of
variance using group as a between-subjects factor and
time as a within-subjects factor. If a time × group inter-
action was detected, independent-samples t tests were
performed at the end of the 6-h resuscitation period
used for Lac kinetics and at the end of the experiment.
In cases of non-normal distribution, time effects within
each group were separately assessed by Friedman’s test
followed by a Mann-Whitney U test at the end of the 6-
h resuscitation period and at the end of the experiment
for differences between groups. To account for testing
twice, the significance level was reduced from 0.05 to
0.025 (Bonferroni correction). IBM SPSS Statistics ver-
sion 21.0 software (IBM, Armonk, NY, USA) was used
for statistical analyses, and Prism version 6.07 software
(GraphPad Software, La Jolla, CA, USA) was used for
graph plotting.
Results
Cohort 1
Twenty-four domestic pigs of both sexes (mean ± SD
weight 40.2 ± 3.8 kg) were analyzed. Of those, 13 of 24
(54.2%) had a decrease in blood Lac levels ≥10% (early
or Lac ≥10% group) and 11 of 24 (45.8%) had a decrease
in blood Lac levels <10% (late or Lac <10%) (Fig. 1).
An additional.pdf file shows this in more detail (see
Additional file 1: Table S1).
Table 2 Hemodynamics and arterial lactate levels in cohort 1
Parameters Group BL BR RP 6 h End p Value
Heart rate, beats/minute Lac ≥10% 94 ± 20 160 ± 40 165 ± 26 132 ± 34 0.369a
Lac <10% 97 ± 17 166 ± 30 161 ± 34 154 ± 33
MAP, mmHg Lac ≥10% 85 ± 12 75 ± 11 82 ± 13 65 ± 10 0.113a
Lac <10% 88 ± 13 77 ± 19 71 ± 12 56 ± 20
MPAP, mmHg Lac ≥10% 14 ± 3 17 ± 3 17 ± 3 21 ± 5 0.594a
Lac <10% 15 ± 6 17 ± 5 20 ± 6 22 ± 4
CVP, mmHg Lac ≥10% 4 ± 1 3 ± 2 3 ± 2 7 ± 2 0.632a
Lac <10% 5 ± 3 2 ± 2 3 ± 2 8 ± 4
Cardiac output, ml/kg/minute Lac ≥10% 131 ± 14 106 ± 16 120 ± 20 151 ± 32 0.618a
Lac <10% 132 ± 22 119 ± 33 122 ± 24 144 ± 46
SVRI, mmHg, L/kg/minute Lac ≥10% 629 ± 112 696 ± 146 677 ± 154 393 ± 92 0.322a
Lac <10% 654 ± 171 652 ± 164 575 ± 164 326 ± 73
SvO2, % Lac ≥10% 55 ± 8 59 ± 11 64 ± 9 63 ± 12 0.264
a
Lac <10% 53 ± 9 57 ± 6 60 ± 6 52 ± 18
DO2, ml/minute Lac ≥10% 625 ± 99 684 ± 116 739 ± 76 653 ± 151 0.796
a
Lac <10% 610 ± 148 702 ± 133 697 ± 156 609 ± 197
VO2, ml/minute Lac ≥10% 273 ± 63 270 ± 86 249 ± 79 220 ± 81 0.987
a
Lac <10% 275 ± 61 281 ± 48 256 ± 60 234 ± 59
O2ER Lac ≥10% 0.44 ± 0.08 0.40 ± 0.11 0.34 ± 0.10 0.34 ± 0.13 0.511
a
Lac <10% 0.46 ± 0.09 0.41 ± 0.05 0.37 ± 0.06 0.43 ± 0.18
Fractional carotid artery blood flow, % Lac ≥10% 5.8 ± 1.9 4.7 ± 1.8 4.6 ± 1.5 4.4 ± 1.5 0.340a
Lac <10% 5.8 ± 1.2 5.4 ± 1.3 5.6 ± 1.3 5.0 ± 2.0
Fractional femoral artery blood flow, % Lac ≥10% 3.3 ± 1.1 2.0 ± 0.5 1.7 ± 0.5 1.9 ± 0.5 0.499a
Lac <10% 3.3 ± 0.8 2.1 ± 0.7 2.2 ± 0.9 2.1 ± 0.8
Arterial Lac, mmol/L Lac ≥10% 0.8 ± 0.1 1.4 ± 0.7 1.1 ± 0.6 1.1 ± 0.7 0.124a
Lac <10% 0.9 ± 0.3 1.6 ± 1.2 1.9 ± 1.4 2.3 ± 2.5
Abbreviations: BL Baseline, BR Immediately before start resuscitation, RP Resuscitation period, End End of the experiment (at 48 h of resuscitation or before death if
earlier), MAP Mean arterial blood pressure, MPAP Mean pulmonary arterial pressure, CVP Central venous pressure, SVRI Systemic vascular resistance index, SvO2
Mixed venous oxygen saturation, DO2 Oxygen delivery, VO2 Oxygen consumption, O2ER Oxygen extraction ratio
Values represent mean ± SD
aTime × group interaction with repeated-measures analysis of variance including all time points
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Mortality
One of 13 animals (7.7%) in the Lac ≥10% group and 4
of 11 animals (36.4%) in the Lac <10% group died during
the resuscitation period (p = 0.082) (Fig. 2).
Administered treatments
Doses of administered propofol, midazolam, fentanyl, re-
suscitation fluids, norepinephrine, and dobutamine, as
well as net fluid balance, did not differ between the Lac
≥10% and Lac <10% groups (Table 1).
Hemodynamics and respiratory and acid-base parameters
Systemic and regional hemodynamics and oxygenation
did not differ between the Lac ≥10% and Lac <10%
groups (Table 2). Respiratory parameters (see Additional
file 1: Table S2), as well as arterial blood gas analysis and
hemoglobin levels (see Additional file 1: Table S3), were
similar in both groups.
Inflammatory markers and skeletal muscle ATP
Plasma IL-6 levels increased during untreated sepsis and
decreased during the resuscitation period in both groups,
but they were lower at the end of the study in the Lac
≥10% group than in the Lac <10% group (p = 0.047)
(Table 3). Plasma TNF-α levels, CRP, and skeletal muscle
ATP content did not differ between groups (Table 3).
Mitochondrial respiration
Complexes I and II maximal (state 3) and resting (state 4)
isolated brain mitochondrial respiration at the end of the
experiment were higher in the Lac ≥10% group than in the
Lac <10% group (Fig. 3 and Additional file 1: Table S4).
Isolated skeletal muscle (see Additional file 1: Table S5),
liver (see Additional file 1: Table S6), and heart (see
Additional file 1: Table S7) mitochondrial respiration
did not differ between the groups.
Cohort 2
Sixteen domestic pigs of both sexes (mean ± SD weight
41.6 ± 2.7 kg) were included in the cohort 2 analysis.
Of those, 7 of 16 (43.8%) exhibited a decrease in blood
Lac levels ≥10% (early group), and 9 of 16 (56.2%) had
a decrease in blood Lac levels <10% (late group) (see
Additional file 1: Table S8 and Figure S1).
Mortality
Three of seven animals (42.9%) in the early (Lac
≥10%) group and eight of nine animals (88.9%) in the
late (Lac <10%) group died during the resuscitation
period (p = 0.006) (Additional file 1: Figure S2).
Hemodynamics
Systemic hemodynamics did not differ between the groups
during the study period (see Additional file 1: Table S9).
Regional blood flow and Lac exchange
Superior mesenteric artery blood flow increased and
renal artery blood flow decreased in both groups during
the 24 h of resuscitation, but both flows were higher at
the end in the Lac ≥10% group than in the Lac <10%
group (Table 4). Similarly, total hepatic blood flow was
higher in the Lac ≥10% group than in the Lac <10%
group at the study end (Table 4). Fractional regional
blood flows are presented in Additional file 1: Table S10.
Hepatic Lac delivery (hepatic Lac influx) and uptake in
the Lac ≥10% group were approximately 1.5 and 3 times
higher, respectively, than in the Lac <10% group at the
end of the study, although statistical significance was
not reached (p = 0.066 for both) (Table 5). Gut,
spleen, kidney, and lung Lac uptake did not differ
between groups (Table 5).
Table 3 Inflammatory markers and skeletal muscle adenosine triphosphate content in cohort 1
Parameters Group BL BR End p Value
IL-6, pg/ml Lac ≥10% 0 (0–0) 854 (481–990) 45 (37–204) 0.003a
Lac <10% 16 (0–180) 873 (531–1983) 166 (128–310) <0.001a
0.047b
CRP, pg/ml Lac ≥10% 1.6 (0.6–2.9) 10.7 (5.6–12.8) 19.2 (9.9–39.8) 0.139c
Lac <10% 3.2 (1.8–5.7) 16.7 (4.9–31.1) 16.7 (13.5–33.3)
TNF-α, pg/ml Lac ≥10% 53 (38–55) 119 (94–169) 72 (47–88) 0.579c
Lac <10% 47 (37–67) 178 (120–219) 92 (57–144)
ATP content, μmol/g wet tissue weight Lac ≥10% 2.1 (1.2–2.3) 2.3 (1.8–3.1) 0.6 (0.4–0.9) 0.081c
Lac <10% 2.8 (1.8–4.5) 3.3 (1.5–4.8) 0.6 (0.3–0.7)
Abbreviations: ATP Adenosine triphosphate, BL Baseline, BR Immediately before start resuscitation, End End of the experiment (at 48 h of resuscitation or before
death if earlier), IL-6 Interleukin-6, CRP C-reactive protein, TNF-α Tumor necrosis factor-α
Values represent median (IQR)
aTime effect with Friedman’s test including all time points
bMann-Whitney U test at end of study
cTime × group interaction with repeated-measures analysis of variance including all time points
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Hepatic function and oxygen consumption
Serum alanine aminotransferase, aspartate aminotransfer-
ase, total bilirubin, and hepatic oxygen consumption did
not differ between groups (see Additional file 1: Table S11).
Discussion
The main finding of the present study was that a de-
crease in blood Lac levels ≥10% during the first 6 h of
resuscitation, regardless of the delay in starting resusci-
tation, was associated with lower levels of IL-6 and
higher brain mitochondrial respiration after 48 h of re-
suscitation. The enhanced decrease in Lac levels (early
group) was associated with higher absolute and relative
(fraction of cardiac output) abdominal blood flows fa-
voring higher hepatic Lac delivery and uptake.
Lac and inflammation have been linked recently in dif-
ferent contexts and diseases, including in cancer [18],
asthma [19], and abdominal surgery [20]. During experi-
mentally induced systemic inflammatory conditions (e.g.,
acute pancreatitis and acute hepatitis) Lac may downreg-
ulate Toll-like receptor 4, NLRP3 (NACHT, LRR, and
PYD domains-containing protein 3) inflammasome, and
concomitantly IL-1β [21]. Nguyen et al. divided 220 pa-
tients with sepsis into 4 different groups according to
Lac kinetics and showed an inverse correlation between
IL-1 receptor antagonist, IL-6, IL-8, IL-10, TNF-α, inter-
cellular adhesion molecule 1, high-mobility group box 1
Fig. 3 Isolated brain mitochondrial respiration in cohort 1 animals. Red horizontal bars represent median values. Black filled circles represent animals that
died during the resuscitation period. p Values provided were calculated with an independent-samples t test or the Mann-Whitney U test. State 3 represents
active respiration after addition of adenosine diphosphate (ADP), and state 4 represents the respiration after depletion of ADP. The respiratory control ratio
(RCR) was calculated by dividing state 3 by state 4 respiration rates. a Complex I. b Complex II. c Complex – IV
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protein, D-dimer, and caspase-3 concentrations and Lac
clearance quartiles [22]. We do not have data to evaluate
whether early decreases in blood Lac levels reduced the
extent of inflammation or whether a less aggravated
inflammatory response enhanced Lac handling. It is pos-
sible that pronounced inflammation directly or indirectly
impedes the ability of mitochondria to use Lac as a cru-
cial alternative source of energy [23, 24]. In a study of
endotoxemic sheep, both esmolol and dexmedetomidine
improved exogenous Lac clearance [23]. The study au-
thors suggested that the anti-inflammatory properties of
these two drugs may have contributed to this finding.
The importance of Lac as a mitochondrial substrate was
reinforced with the Lac shuttle theory [24] and, very re-
cently, with the demonstration that cytosolic Lac can be
directly metabolized within mitochondria by an intrinsic
nicotinamide adenine dinucleotide-dependent L-lactate
dehydrogenase [25, 26]. Increased use of Lac by cerebral
mitochondria in animals in our Lac ≥10% group could
theoretically explain better mitochondrial respiration.
Whereas mitochondrial respiration was higher in brain
biopsies of our Lac ≥10% group animals, it was not in
biopsies of heart, liver, and skeletal muscle. On one
hand, in sepsis, use of substrates and mitochondrial
respiration efficiency vary between organs [27]. On the
other hand, brain mitochondria may be especially vul-
nerable to toxic products released as a consequence of
septic liver dysfunction [28]. For example, hyperammo-
nemia can compromise energy metabolism by inhibition
of α-ketoglutarate dehydrogenase in cerebral isolated
mitochondria [29, 30].
In our Lac ≥10% group, state 3 as well as state 4 res-
piration was slightly higher than in our Lac <10% group,
indicating mild uncoupling of respiration due to proton
leak. Mild uncoupling is not associated with decreasing
ATP synthesis rates [31]. Proton leak across the mito-
chondrial inner membrane may be mediated by compo-
nents of the mitochondrial inner membrane proteins,
such as uncoupling proteins and adenine nucleotide
translocase [32]. Mild uncoupling can be helpful in pro-
tecting against oxidative damage by reducing reactive
oxygen species (ROS) production [33, 34]. It has been
shown that ROS can activate the transcription factor nu-
clear factor-κB (NF-κB) [35] and that activation of IL-6
gene expression occurs through NF-κB [36], which may
explain higher levels of IL-6 in our Lac <10% group.
Numerically higher hepatic Lac uptake in the Lac
≥10% group of cohort 2 may indicate better-preserved
liver function in this group. We cannot judge the effect
of increased liver perfusion (and hence Lac delivery) on
liver Lac uptake. In a short-term endotoxemic shock
model in sheep, exogenous Lac clearance decreased des-
pite maintained liver perfusion [37]. Nevertheless, the
authors in that study did not address the relationship
between (widely varying) liver perfusion and exogenous
Lac clearance in their endotoxemic animals [37]. It has
been shown that, in sepsis, the gut releases, among other
substances, adrenomedullin, a potent vasodilatory pep-
tide [38]. In our study, the other monitored organs did
not play a major role in Lac uptake.
Our findings must be interpreted with caution, mainly
regarding inadvertent attempts to establish cause-and-
effect relationships, because this was a hypothesis-
generating study. On one hand, the different design of the
two analyzed studies is a limitation. On the other hand,
mortality trend differences were consistent between the
early (Lac ≥10%) and late (Lac <10%) groups when resus-
citation followed immediately after the septic insult or was
delayed. Thus, another limitation is that we did not
measure Lac uptake of the brain and the heart, two organs
where mitochondrial Lac use has been demonstrated pre-
viously [23, 24]. Furthermore, in vitro mitochondrial
respiration may not directly reflect in vivo conditions in
diseases where substrate availability may be altered. The
association between Lac time course, inflammation, and
brain mitochondrial function in a clinically relevant model
of sepsis suggests that inflammation may modify brain
mitochondrial respiration. To evaluate this further,
changes in brain tissue inflammation and mitochondrial
respiration should be studied.
Conclusions
A decrease in blood Lac level ≥10% is associated with
lower levels of plasma IL-6 and better brain mitochon-
drial respiration during the first 6 h of resuscitation after
experimental sepsis induced by fecal peritonitis. In-
creased liver Lac uptake may account at least partially
for the differences.
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